Assessment of the efficiency of low level laser therapy in women with primary fibromyalgia syndrome: a randomized, placebo-controlled, double-blind study.
PDF
Cite
Share
Request
Original Article
P: 288-293
2020

Assessment of the efficiency of low level laser therapy in women with primary fibromyalgia syndrome: a randomized, placebo-controlled, double-blind study.

Acta Haematol Oncol Turc 2020;53(2):288-293
1. Department of Physical Therapy and Rehabilitation Fatsa State Hospital, Ordu
2. Department of Rheumatology, Ankara City Hospital Hospital, Ankara
3. Department of Physical Therapy and Rehabilitation Yenimahalle Training and Research Hospital, Ankara
4.
No information available.
No information available
Received Date: 2020-05-06T11:17:13
Accepted Date: 2020-09-04T11:05:01
PDF
Cite
Share
Request

Abstract

INTRODUCTION

This study investigates the efficiency of low level laser therapy (LLLT) in the treatment of clinical symptoms and improvement of the quality of life in patients diagnosed with primary fibromyalgia syndrome (FMS).

METHODS

Sixty primary FMS patients were randomly divided into two groups: active gallium-arsenide (GaAs) laser (30 patients) and placebo laser (30 patients). All the patients were assessed in terms of recovery rates in tender point quantity, pain, morning stiffness, sleep disorder, fatigue, muscle spasm, subjective swelling and paresthesia. Assessment of the quality of life was performed according to the fibromyalgia impact questionnaire (FIQ). Two minutes of 4,4 J/cm2 Ga-As laser therapy to every point was applied to the patients in the active laser group for 10 days. For placebo therapy, the application was applied for the same period of time without radiating any laser beams.

RESULTS

After the treatment, statistically significant recovery was observed in both groups in terms of all parameters.

DISCUSSION AND CONCLUSION

Our results suggest that application of LLLT is effective in the treatment of FMS and emotional factors may play an important role in its etiopathogenesis.